Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.30 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.30 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28065159 | 0.89 | CYP2C19 (0.38) | CYP2C19POLBBLMATM | |
| SCHEMBL19640254 | 0.85 | CYP2C19 (0.35) | CYP2C19POLBBLMATMHDAC3 | |
| SCHEMBL3680780 | 0.83 | CYP2C19 (0.36) | CYP2C19POLBBLMATMHDAC3 | |
| SCHEMBL15298634 | 0.81 | CHRNB2 (0.39) | — | |
| SCHEMBL2489412 | 0.78 | CES2 (0.37) | HDAC11 | |
| SCHEMBL29488592 | 0.77 | CYP2C19 (0.32) | CYP2C19POLBBLMATM | |
| SCHEMBL19640265 | 0.77 | CYP2C19 (0.38) | CYP2C19POLBBLMATM | |
| SCHEMBL28345659 | 0.76 | HDAC3 (0.36) | CYP2C19POLBBLMATMHDAC3 | |
| SCHEMBL4971701 | 0.76 | HDAC3 (0.36) | CYP2C19POLBBLMATMHDAC3 | |
| SCHEMBL27646679 | 0.76 | HDAC3 (0.36) | CYP2C19POLBBLMATMHDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9000092-B2 | Rubber composition comprising a blocked mercaptosilane coupling agent | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2015-04-07 | — | — | US | disclosed |
| US-9000092-B2 | Rubber composition comprising a blocked mercaptosilane coupling agent | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2015-04-07 | — | — | US | disclosed |
| US-20150005448-A1 | RUBBER COMPOSITION COMPRISING A BLOCKED MERCAPTOSILANE COUPLING AGENT | MICHELIN RECHERCHE ET TECHNIQUE S.A. (CH) | 2015-01-01 | — | — | US | disclosed |
| US-20150005448-A1 | RUBBER COMPOSITION COMPRISING A BLOCKED MERCAPTOSILANE COUPLING AGENT | MICHELIN RECHERCHE ET TECHNIQUE S.A. (CH) | 2015-01-01 | — | — | US | disclosed |
| EP-2791226-A1 | RUBBER COMPOSITION COMPRISING A BLOCKED MERCAPTOSILANE COUPLING AGENT | Compagnie Générale des Etablissements Michelin (FR) | 2014-10-22 | — | — | EP | disclosed |
| EP-2379633-B1 | RUBBER COMPOSITION COMPRISING A BLOCKED MERCAPTOSILANE COUPLING AGENT | MICHELIN & CIE (FR) | 2014-05-07 | — | — | EP | disclosed |
| WO-2013087693-A1 | RUBBER COMPOSITION COMPRISING A BLOCKED MERCAPTOSILANE COUPLING AGENT | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2013-06-20 | — | — | WO | disclosed |
| WO-2013087693-A1 | RUBBER COMPOSITION COMPRISING A BLOCKED MERCAPTOSILANE COUPLING AGENT | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2013-06-20 | — | — | WO | disclosed |
| US-20110306700-A1 | RUBBER COMPOSITION COMPRISING A BLOCKED MERCAPTOSILANE COUPLING AGENT | MICHELIN RECHERCHE ET TECHNIQUE S.A. (SE) | 2011-12-15 | — | — | US | disclosed |
| EP-2379633-A1 | RUBBER COMPOSITION COMPRISING A BLOCKED MERCAPTOSILANE COUPLING AGENT | Société de Technologie MICHELIN (FR) | 2011-10-26 | — | — | EP | disclosed |
| WO-2010072682-A1 | RUBBER COMPOSITION COMPRISING A BLOCKED MERCAPTOSILANE COUPLING AGENT | SOCIETE DE TECHNOLOGIE MICHELIN (FR) | 2010-07-01 | — | — | WO | disclosed |
| US-20100145089-A1 | PREPARATION OF (POLY)SULFIDE ALKOXYSILANES AND NOVEL INTERMEDIATES THEREFOR | RHODIA OPERATIONS (FR) | 2010-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100145089-A1 | PREPARATION OF (POLY)SULFIDE ALKOXYSILANES AND NOVEL INTERMEDIATES THEREFOR | TST, CTH, CBS | CYP2C19 3491/4885POLB 3097/4885BLM 1867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.